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Abstract
Background: Acute kidney injury is a common complication after major surgery. In this study, we investigated
whether an algorithm-guided goal-directed haemodynamic therapy (GDT) can improve renal outcome compared
to good standard clinical care.
Methods: A total of 180 patients undergoing major abdominal surgery were prospectively and randomly assigned
to one of two groups: in the GDT group, patients were treated with a GDT algorithm using transpulmonary
thermodilution while standard care was applied to the control patients. Change in creatinine was studied as the
primary end point, postoperative complications as well as 1-year mortality as secondary outcomes. Haemodynamics
in GDT and control patients were compared calculating goal-achievement rates.
Results: Postoperative change in creatinine (18 ± 39 μmol/l (control) vs. 16 ± 42 μmol/l (GDT); mean difference
(95 % confidence interval) 1.6 μmol/l (−10 to 13 μmol/l)) was comparable between the GDT and the control group.
Postoperative complications and mortality during hospital stay and after 1 year were not influenced by the use of a
GDT algorithm. Achievement rates of haemodynamic goals were not higher in the GDT group compared to the
already high (>80 %) rates in the control group. Multivariate regression analysis revealed intraoperative hypotension
(MAP < 70 mmHg) and postoperative hypovolaemia (GEDI < 640 ml/m2) as risk factors for postoperative renal
impairment.
Conclusions: In this study, GDT was not superior to standard clinical care in order to avoid renal failure after major
abdominal surgery. The reason for this finding is most likely the high achievement rate of haemodynamic goals in
the control group, which cannot be improved by the GDT algorithm.
Trial registration: Clinicaltrials.gov; NCT01035541; registered 17 December 2009.
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Background
Acute kidney injury is a common complication after major
non-cardiac surgery and is associated with increased mor-
tality [1–4]. Hypoperfusion and haemodynamic instability
resulting in a mismatch of oxygen demand and delivery
are discussed in the pathogenesis of postoperative renal
impairment, raising the question whether perioperative
goal-directed haemodynamic therapy (GDT) might im-
prove postoperative renal outcome [5, 6]. In this context,
one meta-analysis focusing on kidney function stated that
perioperative haemodynamic optimisation improves renal
outcome. However, most of the studies investigated vascu-
lar and cardiac surgery patients and used a composite end
point of perioperative morbidity in lieu of renal outcome
[7]. Therefore, it is not known yet, whether an algorithm-
guided GDT is superior to a haemodynamic therapy
guided by established clinical standard of care in order to
avoid renal failure after non-cardiac surgery.
Any GDT is primarily focusing on haemodynamic sta-
bility characterized by achieving defined haemodynamic
goals. Therefore, the comparison of an algorithm-guided
GDT with standard clinical care requires screening of
these haemodynamic goals with an extended GDT
monitor in both investigational groups. As just a few
studies have recorded achievement rates of haemo-
dynamic goals in both the algorithm-guided GDT as well
as the standard clinical care, the conclusion that the use
of a GDT algorithm can effectively improve haemo-
dynamic state cannot be drawn yet.
The aim of this study was to investigate if an intra- and
postoperative GDT algorithm can improve renal outcomes
after major abdominal surgery compared to standard clin-
ical care. Further, this study analysed if the achievement
rate of haemodynamic goals is higher in patients treated
with a GDT algorithm compared to controls. Finally, other
non-renal postoperative complications and mortality were
studied up to 1 year after surgery as secondary end points.
Methods
The study is a prospective randomised trial and was ap-
proved by the local ethics committee (Ethikkomission
der Fakultät für Medizin der Technischen Universität
München; ID: 2538/09) and was registered at the registra-
tion site of the US National Institutes of Health (clinical-
trials.gov; Identifier: NCT01035541; principal investigator:
Jungwirth Bettina; date of registration 17 December 2009).
This prospective, randomised, single-centre study was
performed at an University Hospital in Munich, Germany.
Patients were included from March 2010 until December
2012 and were followed up to 12 months after surgery,
when a telephone interview was performed in order to as-
sess morbidity and mortality. The trial ended after the
number of patients determined in the sample size calcula-
tion was enrolled.
Study population
We included patients older than 18 years, American Society
of Anesthesiologists (ASA) physical status classification 1–3
undergoing major non-cardiac surgery planned to last
at least 3 hours with an expected subsequent intensive
care treatment of more than 3 days. Exclusion criteria
were need for dialysis and contraindication for an arterial
line in the femoral artery. One research team member
evaluated patients’ eligibility, informed them in detail
about the study and obtained informed consent.
Anaesthesia
If no contraindications existed, an epidural catheter was
inserted before induction of anaesthesia. All patients re-
ceived general anaesthesia with sufentanil and propofol
for induction and sevoflurane for maintenance of anaes-
thesia. Rocuronium was used as a muscle relaxant. After
induction, an 8.5 French central venous catheter was
placed in the internal jugular vein and a 5 French
thermistor-tipped catheter in the femoral artery. Before
surgical incision, an epidural bolus of 10 μg sufentanil
and 16 mg ropivacaine was applied. For pain therapy, a
continuous epidural infusion of 3 μg sufentanil and 4.8
mg ropivacaine per hour (patient height < 175 cm) or 4
μg sufentanil and 6.4 mg ropivacaine per hour (patient
height > 175 cm) was used.
All patients were monitored with a transpulmonary
thermodilution monitor (PiCCO2®; PULSION Medical
Systems SE, Feldkirchen, Germany). The basal infusion
rate during the whole surgery and at the intensive care
unit was 100 ml/h of Ringer's acetate (RA) in both groups.
Red packed cells were administered when the haemo-
globin level decreased below 8 mg/dl or the patient
showed signs of ischaemia like respective alterations in
the electrocardiogram. Fresh frozen plasma was given in
the presence of coagulopathy assessed using conven-
tional laboratory parameters and ROTEM® (Tem Inter-
national GmbH, Munich, Germany) diagnostics.
Randomisation
Patients were randomly allocated to one of two groups
in a 1:1 ratio using a computer-generated list: GDT or
control. In the GDT group, the patients’ haemodynamic
conditions were treated according to an established
algorithm, which is an adaption of the one used by
Goepfert in patients undergoing cardiac surgery (Fig. 1)
[8]. In the control group, haemodynamics were managed
using the standard care of our hospital. Prior to an-
aesthesia induction a study team member assessed the
randomisation list.
Intraoperative management – GDT group
A resident and an attending anaesthesiologist performed
anaesthesia in patients of the GDT group with exclusion
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of haemodynamic therapy. A member of the research
team performed haemodynamic therapy according to
the algorithm using the PiCCO® monitor. In detail,
transpulmonary thermodilution measurements were car-
ried out every 30 minutes during anaesthesia [8]. Global
end-diastolic index (GEDI), mean arterial pressure
(MAP) as well as cardiac index (CI) were used as the
main objectives. In case the algorithm recommended a
fluid bolus, 500 ml of hydroxyethyl starch (HES) or RA
were infused within 15 minutes followed by another
thermodilution to confirm that goals were achieved.
When the study was conducted in our hospital, standard
clinical protocol for fluid resuscitation allowed the use
of HES 130/0.4 during surgery and during stay in the
intensive care unit (ICU) with a maximum dose of 50
ml/kg bodyweight per day. The attending anaesthesiolo-
gist/intensivist decided according to personal preferences
whether to use HES or RA for fluid resuscitation. In order
to consider a potential negative effect of HES on renal
function, we recorded the total amount of HES used in
our patients. Norepinephrine was used as a vasopressor,
dobutamine as an inotrope.
Intraoperative management – control group
A resident and an attending anaesthesiologist performed
anaesthesia in patients of the control group including
haemodynamic therapy according to the standard care
of our hospital. Haemodynamic monitoring incorporates
invasive blood pressure monitoring, which was not able to
automatically calculate advanced haemodynamic parame-
ters like pulse pressure variation or systolic pressure vari-
ation. Fluids and catecholamines were administered at the
attending anaesthetist’s discretion. In addition, a member
of the research team implemented the PiCCO® monitor
and performed transpulmonary thermodilution after in-
duction and then every 30 minutes but did not communi-
cate the results of the pulse contour or thermodilution
measurements. The PICCO® monitor was additionally
covered during the whole study period.
Management in the intensive care unit
In both groups, the monitoring with transpulmonary
thermodilution was continued in the intensive care unit
until 72 hours after surgery and was calibrated every
8 hours. Again, haemodynamic management in patients of
Fig. 1 Treatment algorithm in the goal-directed hemodynamic management group, modified according to [8]. CI cardiac index, ELWI extravascular
lung water index, GEDI global end-diastolic index, MAP mean arterial pressure
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the GDT group was performed according to the algorithm
while haemodynamic therapy in patients of the control
group was at the intensivist’s discretion. In the control
group, the PiCCO® monitor was covered and a person other
than the attending caregiver carried out the thermodilution.
Outcomes
The primary end point was the maximum change in
serum creatinine and in creatinine clearance within 7
days after the operation. Therefore, blood samples were
taken daily during the ICU stay and at least once on the
normal ward. Creatinine clearance was calculated using
age and gender according to the modification of diet in
renal disease (MDRD) formula.
As pre-specified secondary outcome measures, we
assessed the stage of acute postoperative renal failure using
the risk, injury, failure, loss of kidney function and end-
stage renal disease (RIFLE) criteria during the ICU stay [9].
We analysed creatinine, glomerular filtration rate (GFR)
and hourly urine output to determine RIFLE criteria. In
addition, we performed an exploratory analysis using these
parameters in order to determine the incidence of acute
kidney injury according to the Kidney Disease; Improving
Global Outcome (KDIGO) definition, a new definition for
acute kidney injury updated in 2012 after commencement
of our study [6]. After discharge from the ICU the need for
dialysis was recorded. Further outcome parameters like
surgical re-intervention, respiratory (pulmonary oedema,
pleural infection, re-intubation and prolonged ventilation)
and cardiocirculatory (myocardial infarction and prolonged
hypotension) complications, sepsis and postoperative mor-
tality were assessed during the hospital stay. The incidence
of delirium in the ICU was determined with the confusion
assessment method (CAM). Acute physiology and chronic
health evaluation II (APACHE II) and sequential organ fail-
ure assessment (SOFA) scores were evaluated every day
during the ICU stay.
Effect of goal-directed therapy
In order to compare the haemodynamics of GDTand con-
trol patients we analysed the achievement rates of haemo-
dynamic goals. For this purpose, all haemodynamic data
were saved on the PiCCO® monitor every 12 seconds
using the integrated data recording system. In addition,
the results of the transpulmonary thermodilution were
documented in a case report form. Due to breakdowns of
the internal recording system, especially during the early
phase of the study, continuous data of 13 patients (seven
GDT, six control) are not available. In these patients only
the results of the transpulmonary thermodilution have
been analysed. The goal-achievement rate was calculated
dividing the number of measurements the parameter
was within the target range of the algorithm by the
total number of measurements.
One-year follow-up
One year after the operation patients were contacted via
telephone. A questionnaire investigating the patients’
state of health (Additional file 1) and a 12-item short-form
health survey (SF-12) telephone questionnaire were com-
pleted with the patient. In cases where the patient had
died, the next-of-kin was asked about the date and cause
of death. Furthermore in cases when we were not able to
reach the patient, the hospital record was reviewed
for information about health status and survival during
the last year. We introduced the 1-year follow-up after 17
patients (ten GDT, seven control) had already been in-
cluded. As these patients had not been informed about
the 1-year interview, their data are missing.
Statistical analysis
Calculation of sample size was based on data from pa-
tients who underwent major surgery fulfilling the inclu-
sion criteria in the months March and July 2009 in our
hospital. Expecting a reduction of maximum creatinine
change by 40 % (80 % power, p < 0.05 at two-sided error)
a sample size of 90 patients per group was calculated.
In a confirmatory approach, primary as well as secondary
outcomes were compared between GDT and standard
treatment. Mean or median difference and their 95 % con-
fidence interval (CI) were evaluated with independent t test
or Mann-Whitney U test according to their distribution.
Dichotomic parameters were compared with odds ratio
and 95 % CI by generalised linear modelling of a binary
logistic regression model. Significance level was p < 0.05.
In an observatory approach, the effects of further risk
factors as well as the achievement rates of haemodynamic
objectives on postoperative renal outcome were analysed
with a multivariate linear regression model using the abso-
lute decrease of the creatinine clearance as dependent
variable. We tested the independent factors, type of fluid,
age, sex, body mass index, infusion rate of noradrenaline
and dobutamine and the ratio within the target range of
mean arterial pressure, cardiac index, global end-diastolic
index and extravascular lung water index during the oper-
ation and the ICU observation period.
Calculations were done with IBM SPSS Statistics®
(Version 21.0; IBM Corp., Armonk, NY, USA). Metric
data are expressed as mean and standard deviation (SD)
or median and range (minimum to maximum) as appro-
priate, categorical data as number and percentage.
Results
Patient characteristics, anaesthesia, and haemodynamic
therapy
We screened 212 patients for eligibility. A total of 193
patients were randomised and 180 analysed. Thirteen
patients were excluded from the analysis, as they did not
receive the allocated intervention, that means surgery
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was terminated due to unexpected findings during the
operation (for example metastases, peritoneal carcino-
sis). Ninety-two patients in the GDT group received the
allocated intervention and 88 in the control group. Al-
though in nine patients (five GDT, four control) protocol
violations were observed, we decided to include these
patients in our analysis (Fig. 2). Baseline characteristics
showed no difference between the two groups regarding
preoperative serum creatinine or creatinine clearance or
pre-medical condition (Table 1). Due to contraindica-
tions five patients did not receive epidural anaesthesia
(three GDT, two control).
The total amount of RA and HES infused did not differ
between the GDT and control group. More dobutamine
was used in the GDT group during surgery compared to
the control group. The amount of vasopressor was not
different between groups (Table 2). The overall transfusion
rate was low with 0.5 red packed cells and 0.3 fresh frozen
plasma units per patient and was not different between
groups. In total only 41 patients received red packed cells
and 14 patients fresh frozen plasma units.
Confirmatory analyses
The change in creatinine and creatinine clearance within
the first 7 postoperative days did not differ between the
GDT and control group. RIFLE criteria determined during
ICU stay as well as the need for dialysis after ICU were
not different between the two groups. The exploratory
analysis according to the KDIGO definition of acute kid-
ney injury did not detect any differences between the two
groups. No patient developed end-stage renal disease.
The incidence of all postoperative complications as well
as mortality was not different between the two study
groups (Table 3). There was also no difference between the
control and GDT groups regarding APACHE II (6.7 ± 2.8
vs. 6.9 ± 1.4) and SOFA (1.1 ± 1.7 vs. 1.4 ± 1.7) score.
Fig. 2 CONSORT flow diagram. GDT goal-directed haemodynamic therapy
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One year after surgery we tried to contact 163 of the 180
patients. Seventeen were not contacted, as their informed
consent for the telephone interview was missing due to the
later amendment to the ethics committee as mentioned in
the Methods section. For determination of 1-year mortality
(including in-hospital mortality), we combined the informa-
tion on the patients’ electronic record with that of the tele-
phone interviews. Therefore, data on 1-year mortality was
available for 154 of the 163 patients investigated (94 %) and
did not differ between the two groups (Table 3). All other
long-term outcome parameters did not differ between the
control and GDTgroups as well (Table 3).
Implementation of a GDT algorithm did not result in
higher rates of achieving haemodynamic objectives when
compared to control patients. In contrast, MAP was more
often above 70 mmHg in control patients as compared to
GDT patients. The median achievement rates of CI were
high and comparable between patients of the GDT and
the control group. The minimum of the achievement rate
was low for CI in both groups so that some patients did
not reach the designated CI > 2.5 l/min/m2. Furthermore
all haemodynamic parameters were more often within
target ranges during ICU stay when compared to the
operation period (Table 4).
Exploratory analysis
Multivariate regression analysis showed an impact of
body mass index and preoperative creatinine clearance
on postoperative change in creatinine clearance. Further,
the achievement rate of MAP above 70 mmHg during
operation, and the achievement rate of GEDI above 640
ml/m2 during ICU stay influenced the postoperative
renal outcome. Last but not least, the multivariate regres-
sion analysis showed a negative impact of HES on the
postoperative creatinine clearance. The achievement rates
Table 1 Baseline characteristics
Control GDT
Age (year) 65 ± 11 67 ± 12
Body mass index (kg/m2) 21 ± 4 22 ± 5
Gender
Male 70 (80 %) 68 (74 %)
Female 18 (20 %) 24 (26 %)
Preoperative renal function
Creatinine (μmol/l) 79 ± 23 81 ± 22
Creatinine clearance (ml/min/1.73 m2) 87 ± 26 83 ± 25
Type of surgery
Whipple 14 (16 %) 16 (18 %)
Oesophageal 65 (74 %) 71 (77 %)
Pancreatectomy 5 (6 %) 3 (3 %)
Other 4 (4 %) 2 (2 %)
Pre-medical condition
Diabetes 15 (17 %) 21 (23 %)
Hypertension 43 (48 %) 58 (63 %)
Chronic renal failure 3 (3 %) 6 (7 %)
Coronary artery disease 12 (13 %) 19 (21 %)
Heart failure 4 (4 %) 7 (8 %)
Arrhythmia 6 (7 %) 12 (13 %)
Valvular disorder 3 (3 %) 3 (3 %)
Haemodynamics after induction
GEDI (ml/m2) 742 ± 164 715 ± 141
MAP (mmHg) 79 ± 17 78 ± 16
CI (ml/min/m2) 2.4 ± 0.5 2.4 ± 0.6
ELWI (ml/kg) 8 ± 2 8 ± 2
Categorical variables are given as number and percentage, continuous
variables as mean ± standard deviation
GDT goal-directed haemodynamic therapy, GEDI global end-diastolic index,
MAP mean arterial pressure, CI cardiac index, ELWI extravascular lung
water index
Table 2 Fluids and catecholamines administered. Comparison between intervention groups
Control GDT Mean diff. (95 % CI) p value
Fluids
RA (ml) OP 2316 ± 1800 2529 ± 2169 202 (−210 to 614) 0.34
ICU 8052 ± 3277 8597 ± 3147 557 (−386 to 1499) 0.25
HES (ml) OP 847 ± 1045 801 ± 1080 −50 (−237 to 138) 0.60
ICU 701 ± 1188 514 ± 1083 −199 (−489 to 88) 0.17
Catecholamines
Noradrenaline (μg/kg/min) OP 0.03 ± 0.03 0.03 ± 0.06 0.00 (−0.02 to 0.01) 0.71
ICU 0.01 ± 0.04 0.03 ± 0.08 0.02 (−0.01 to 0.03) 0.14
Dobutamine (μg/kg/min) OP 0.00 ± 0.03 0.74 ± 2.61 0.73 (0.18 to 1.29) 0.01
ICU 0.13 ± 0.96 0.39 ± 1.56 0.26 (−0.13 to 0.64) 0.19
Variables are given as mean ± standard deviation
GDT goal-directed haemodynamic therapy, diff. difference, CI confidence interval, RA Ringer’s acetate, HES hydroxyethyl starch, OP operation, ICU intensive care
unit (the first 72 hours)
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of all other haemodynamic objectives and the infusion rate
of catecholamines demonstrated no impact on renal out-
come (Table 5).
In the operating theatre the achievement rate of
MAP, GEDI and CI was significantly better in patients
who were treated with HES compared to RA. Median
difference (95 % confidence interval) and p value for
HES compared to RA: MAP > 70 mmHg: 0.06 (0.02
to 0.11) p = 0.006; CI > 2.5 l/min/m2: 0.10 (0.03 to
0.19) p = 0.002; GEDI > 640 ml/m2: 0.11 (0.00 to 0.23)
p < 0.0019. This effect was not evident at the intensive
care unit.
Discussion
In our study an algorithm-guided GDT was not accom-
panied with a reduced risk of postoperative renal failure
or other short- and long-term complications compared
to good standard clinical care. This is most likely due
to the unexpected high achievement rate of haemo-
dynamic goals in control patients with no further im-
provement in patients in whom the GDT algorithm
was applied. Using a multivariate analysis, short-term
postoperative renal outcome was influenced by body
mass index and preoperative creatinine clearance as
immutable factors as well as by intraoperative
Table 3 Primary as well as short- and long-term secondary outcome parameters
Control GDT Mean diff. (95 % CI) Odds ratio (95 % CI) p value
Primary renal outcomes
Change in creatinine (μmol/l) 18 ± 39 16 ± 42 1.6 (−10 to 13) 0.788
Change in creatinine clearance (ml/min/1.73 m2) −12 ± 24 −10 ± 24 −2 (−9 to 5) 0.566
Secondary outcomes (hospital stay)
Incidence of acute kidney injury according to RIFLE
(first line: all patients with RIFLE≥ 1)
45/88 (51 %) 54/92 (59 %) 0.73 (0.41 to 1.33) 0.31
R: 29/88 R: 30/92
I: 14/88 I: 22/92
F: 2/88 F: 2/92
Incidence of acute kidney injury according to KDIGO
(first line: all patients with AKI≥ 1) (Exploratory endpoint)
46/88 (52 %) 53/92 (58 %) 0.81 (0.45 to 1.45) 0.47
1: 34/88 1: 30/92
2: 10/88 2: 21/92
3: 2/88 3: 2/92
Need for dialysis after RIFLE observation period 4/88 (5 %) 5/92 (5 %) 0.83 (0.21 to 3.23) 0.78
Incidence of ≥1 surgical re-intervention 19/88 (22 %) 24/92 (26 %) 0.78 (0.39 to 1.56) 0.48
Incidence of ≥1 postoperative respiratory complicationa 28/88 (32 %) 28/92 (30 %) 1.07 (0.57 to 2.01) 0.84
Incidence of ≥1 postoperative cardiocirculatory complicationb 2/88 (2 %) 6/92 (7 %) 0.33 (0.07 to 1.70) 0.19
Incidence of postoperative sepsis 7/88 (8 %) 7/92 (8 %) 1.05 (0.35 to 3.19) 0.93
Incidence of postoperative delirium 12/70 (17 %) 18/75 (24 %) 0.65 (0.29 to 1.48) 0.31
In-hospital mortality 4/88 (5 %) 4/92 (4 %) 0.79 (0.28 to 2.21) 0.65
Secondary outcome (one year)
Incidence of hospital re-admission 36/65 (55 %) 28/65 (43 %) 1.64 (0.82 to 3.28) 0.16
Incidence of re-admission to ICU 11/64 (17 %) 11/65 (17 %) 1.02 (0.41 to 2.55) 0.97
Incidence of surgical re-intervention 28/67 (42 %) 20/66 (30 %) 1.65 (0.08 to 3.38) 0.17
Incidence of new need for dialysis after discharge 1/64 (2 %) 2/63 (3 %) 0.48 (0.04 to 5.48) 0.56
Incidence of myocardial infarction 0/64 (0 %) 3/65 (5 %) n.a. 0.24c
Incidence of stroke 1/64 (2 %) 0/63 (0 %) n.a. 1.00c
SF-12 Quality of life physical sum score 45.3 ± 9.1 45.0 ± 11.1 0.25 (−4.9 to 5.4) 0.92
SF-12 Quality of life mental sum score 50.6 ± 10.4 50.9 ± 10.3 −0.27 (−5.5 to 5.0) 0.92
One-year overall mortality 16/77 (21 %) 22/77 (29 %) 0.66 (0.31 to 1.37) 0.26
Variables of primary renal outcome and SF-12 are given as mean ± standard deviation and variables of secondary outcome as number of patients showing the
complication (n) in relation to the number of treated patients within the respective group (N) and incidence (%)
GDT goal-directed haemodynamic therapy, diff. difference, CI confidence interval, RIFLE risk, injury, failure, loss, end-stage kidney disease, R risk, I injury, F failure,
KDIGO Kidney Disease: Improving Global Outcome, AKI acute kidney injury, ICU intensive care unit, n.a. not applicable, SF-12 12-item short-form health survey
aPulmonary edema, pleural infection, re-intubation and prolonged ventilation
bMyocardial infarction and prolonged hypotension
cFisher’s exact test
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hypotension, postoperative hypovolaemia and the use
of HES as controllable factors.
The question of whether GDT improves postoperative
outcome is still under debate, just as the discussion
about the best monitor [10–15]. Studies providing con-
troversial results used heterogeneous haemodynamic
monitors with different algorithms, starting haemo-
dynamic therapy at different times for various durations.
Our study focused on renal impairment, which could
occur during or after major surgery. Therefore, it was of
importance to study the whole perioperative period of
intensive observation that is intraoperative and in the
ICU [16, 17]. This long observation period with different
ventilation modalities from controlled ventilation during
the operation to spontaneous breathing in the ICU
requires a haemodynamic monitor, which enables the
assessment of preload independent of the mode of
ventilation. GEDI as a volumetric parameter has been
shown to be valid during different ventilation modes
and in the presence of arrhythmia [18]. Next to preload,
cardiac output and perfusion pressure are discussed
as important parameters in order to avoid postoperative
complications [12, 19]. Therefore, we employed the
PiCCO® monitor with Goepfert’s algorithm using GEDI,
CI and MAP as the main objectives [8].
Several studies have shown that algorithm-guided GDT
can improve postoperative outcomes. The underlying
mechanisms are assumed to be better haemodynamic sta-
bility compared to standard clinical care [14]. However,
haemodynamic stability characterized by better achieve-
ment of haemodynamic goals was rarely measured in
standard clinical care patients. The few studies reporting
these achievement rates showed very low rates in control
patients (19 % and 60 %) [20, 21]. In contrast, our study
revealed achievement rates of GEDI, CI and MAP in con-
trol patients with 80 % and more as very high, which
might be one reason why the algorithm was not able to
raise the achievement rates in the GDT group. Another
reason could be the algorithm itself: in the GDT group no
preventive measures were undertaken when the MAP was
Table 4 Comparison of achievement rates between intervention groups and between surgery and intensive care unit
Control GDT Control vs. GDT OP vs. ICU
Median diff. (95 % CI) p value Median diff. (95 % CI) p value
Pulse contour data
MAP > 70 mmHg OP 0.85 0.77 −0.06 0.010 0.08 < 0.001
(0.33 – 1.0) (0.33 – 0.99) (−0.11 to −0.02) (0.05 to 0.12)
ICU 0.91 0.90 0.00 0.74
(0.10 – 1.0) (0.29 – 1.0) (−0.03 to 0.02)
CI > 2.5 l/min/m2 OP 0.82 0.75 −0.04 0.20 0.23 < 0.001
(0.01 – 1.0) (0.06 – 1.0) (−0.10 to 0.02) (0.18 to 0.27)
ICU 0.99 0.97 0.00 0.12
(0.72 - 1.0) (0.59 – 1.0) (−0.02 to 0.00)
Thermodilution data
CI > 2.5 l/min/m2 OP 0.79 0.71 −0.04 0.22 0.27 < 0.001
(0.0 – 1.0) (0.0 – 1.0) (−0.13 to 0.00) (0.23 to 0.31)
ICU 1.0 1.0 0.00 0.18
(0.56 – 1.0) (0.50 – 1.0) (0.00 to 0.00)
GEDI > 640 ml/m2 OP 0.90 1.0 0.00 0.70 0.22 0.001
(0.0 – 1.0) (0.0 – 1.0) (0.00 to 0.00) (0.00 to 0.71)
ICU 1.0 1.0 0.00 0.18
(0.0 – 1.0) (0.0 – 1.0) (0.00 to 0.00)
ELWI≤ 10 ml/kg OP 1.00 1.00 0.00 0.06 0.00 0.012
(0.0 – 1.0) (0.0 – 1.0) (0.00 to 0.00) (0.00 to 0.00)
ICU 1.00 1.00 0.00 0.10
(0.13 – 1.0) (0.0 – 1.0) (0.00 to 0.00)
Variables are given as median of the ratio the respective parameter was within the target range relating to the complete observation period and range (minimum
to maximum); continuous data is haemodynamic data saved every 12 seconds with the integrated recording system. Pulse contour data is haemodynamic data
acquired whenever thermodilution was performed
GDT goal-directed haemodynamic therapy, OP operation, ICU intensive care unit, diff. difference, CI confidence interval, MAP mean arterial pressure; CI cardiac
index; GEDI global end-diastolic index; ELWI extravascular lung water index
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decreasing slowly, instead hypotension was not treated
until the MAP was below 70 mmHg. In addition, for the
right treatment a thermodilution was performed as a
time-consuming measurement. In the control group, the
anaesthesiologist had no strict protocol to treat or prevent
hypotension resulting in better rates of achieving the goal
for MAP.
The median of the achievement rates was very high
(Table 3), while the range (minimum to maximum) was
wide, raising the question, whether a low achievement
rate of haemodynamic goals is associated with an in-
creased risk for renal impairment. Therefore, post hoc
multivariate regression analysis was performed and dem-
onstrated that avoiding intraoperative hypotension and
postoperative hypovolaemia is vital for short-term renal
function. In other words, the mere application of an
algorithm does not improve renal outcome as long as it
does not sufficiently avoid haemodynamic instability.
To date, the debate about the safety concerns of HES
is still ongoing culminating in recommendations that the
use of HES should be suspended in critically ill patients
[22, 23]. These recommendations based on several clin-
ical trials and meta-analyses showing negative effects of
HES on renal function and mortality in ICU patients
[24–27]. In contrast, some studies were not able to con-
firm these detrimental effects for the perioperative setting
[28–31]. In our study, post hoc multivariate regression
analysis has shown that the use of HES presents an inde-
pendent risk factor for postoperative renal impairment, al-
though the haemodynamic goals were better achieved
with HES compared to RA.
Results from controlled clinical trials can be trans-
ferred to clinical routine with limitations only. Just the
presence of a covered PiCCO® monitor could have influ-
enced the attending anaesthesiologist’s haemodynamic
management. Another limitation could be the patient
population: we also included healthy individuals under-
going major surgery. Surprisingly, our patients showed a
higher incidence of renal impairment (55 %) according
to RIFLE criteria compared to other studies [1, 2]. This
could be in part due to the fact that we analysed not
only serum creatinine and creatinine clearance but also
hourly urine output on the ICU to determine the highest
RIFLE level, which leads to a more accurate estimation
of renal impairment [32]. The incidence of renal impair-
ment without analysis of urine output in our patient
population is 27 % and therefore comparable to other
studies reporting postoperative acute kidney injury [1].
These incidences could be confirmed in an exploratory
analysis when the newer KDIGO definition of acute kid-
ney injury was applied (incidence 55 % with and 24 %
without analysis of urine output).
Table 5 Multivariate linear regression analysis of factors influencing change of creatinine clearance
Means Regression coefficient (95 % CI) p value
Fluid [= HES] 48 % −8.2 (−15.7 to −0.7) 0.033
Sex [= male] 77 % 1.7 (−7.0 to 10.4) 0.697
Age (year) 66 (64 to 67) −0.4 (−0.8 to 0.0) 0.054
BMI (kg/m2) 22 (21 to 22) −1.8 (−2.7 to −0.8) < 0.001
Preoperative creatinine clearance (ml/min/1.73 m2) 87 (83 to 91) −0.4 (−0.6 to −0.2) < 0.001
MAP > 70 mmHg (achievement rate during whole operation period) 0.77 (0.74 to 0.80) 27.9 (5.9 to 49.8) 0.013
MAP > 70 mmHg (achievement rate during whole ICU observation) 0.85 (0.83 to 0.88) 19 (−2.4 to 41) 0.081
CI > 2.5 l/min/m2 (achievement rate during whole operation period) 0.70 (0.66 to 0.74) −5.8 (−22 to 10) 0.477
CI > 2.5 l/min/m2 (achievement rate during whole ICU observation) 0.95 (0.94 to 0.96) 16.7 (−36.6 to 70.1) 0.536
Noradrenaline infusion ratea during operation (μg/kg/min) 0.03 (0.02 to 0.04) −42 (−111 to 26) 0.222
Noradrenaline infusion ratea during ICU (μg/kg/min) 0.02 (0.01 to 0.03) −60 (−126 to 5.6) 0.073
Dobutamine infusion ratea during operation (μg/kg/min) 0.40 (0.07 to 0.73) 1.4 (−0.9 to 3.8) 0.227
Dobutamine infusion ratea during ICU (μg/kg/min) 0.17 (0.02 to 0.32) −1.7 (−5.6 to 2.2) 0.389
GEDI > 640 ml/m2 (achievement rate during whole operation period) 0.74 (0.69 to 0.79) −9.2 (−26.9 to 8.4) 0.302
GEDI > 640 ml/m2 (achievement rate during whole ICU observation) 0.80 (0.76 to 0.85) 20 (2.3 to 37) 0.027
ELWI < 11 ml/kg (achievement rate during whole operation period) 0.89 (0.86 to 0.93) 15 (−1.8 to 31) 0.079
ELWI < 11 ml/kg (achievement rate during whole ICU observation) 0.93 (0.90 to 0.96) −3.2 (−24 to 18) 0.764
Means are given as percentage of all patients, mean of all patients (95 % confidence interval) or mean of the ratio the respective parameter was within the target
range relating to the complete observation period of all patients (95 % confidence interval)
CI confidence interval, HES hydroxyethyl starch, BMI body mass index, MAP mean arterial pressure, ICU intensive care unit, CI cardiac index, GEDI global end-
diastolic index, ELWI extravascular lung water index
aMean individual infusion rate
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Conclusions
In conclusion, an algorithm-guided GDT using PiCCO2®
monitoring was not able to reduce renal failure after
major abdominal surgery in this study. This finding is
most likely owing to the already high achievement rates of
haemodynamic goals in the standard clinical care group.
Exploratory analysis revealed intraoperative hypotension
(MAP < 70 mmHg), postoperative hypovolaemia (GEDI <
640 ml/m2) and the use of HES as modifiable risk factors
for short-term postoperative renal failure.
Key messages
 Algorithm-guided GDT did not further improve
haemodynamic stability compared to good standard
clinical care in our study.
 Therefore algorithm-guided GDT does not reduce
incidence of renal failure after major non-cardiac
surgery.
 Risk factors for postoperative renal failure are
intraoperative hypotension, postoperative
hypovolaemia and the use of HES.
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